• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Admin

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

@rachel

Profile

Registered: 12 years, 9 months ago


Forums

Topics Started: 2

Replies Created: 0

Forum Role: Keymaster

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Aug 19
8:00 am - 9:00 am EDT

Member Forum: Equitable Access to Care

Aug 19
6:00 pm - 7:00 pm EDT

Member Forum: Equitable Access to Care

Aug 20
11:00 am - 12:00 pm EDT

Les Turner ALS Foundation: ALS-FTD Clinicopathological Overlap

Sep 8
8:00 am - 9:00 am EDT

Member Forum: Health Literacy & Understanding ALS/MND

Sep 8
6:00 pm - 7:00 pm EDT

Member Forum: Health Literacy & Understanding ALS/MND

View Calendar

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Bob Simonds, USA

    Bob Simonds, USA

  • Phil Rossall, UK

    Phil Rossall, UK

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Denis Blais, Canada

    Denis Blais, Canada

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Alex, Argentina

    Alex, Argentina

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • Ali Var, Turkey

    Ali Var, Turkey

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Brian Parsons, Canada

    Brian Parsons, Canada

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Willi Klein, UK

    Willi Klein, UK

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • Olga, Argentina

    Olga, Argentina

  • Lombana, Spain

    Lombana, Spain

  • Timmy, Belgium

    Timmy, Belgium

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login